Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02516878
Other study ID # AcupBWC001
Secondary ID
Status Completed
Phase N/A
First received July 30, 2015
Last updated March 14, 2017
Start date August 2015
Est. completion date December 2016

Study information

Verified date March 2017
Source Hong Kong Baptist University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, a 18-week, single-blinded, randomized controlled clinical trial will be conducted to evaluate the effectiveness, efficacy and safety of acupuncture on weight control in Hong Kong.


Description:

This is a pilot single-blind, randomized, sham-controlled trial. 72 participants will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 8 weeks with 2 sessions per week and the follow-up period will be 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date December 2016
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- aged between 18 and 65 years old;

- body mass index (BMI)=25 kg/m2;

- having not received any other weight control measures or any medical and/or drug history within the last 3 months.

Exclusion Criteria:

- endocrine diseases;

- heart diseases;

- patients with pacemaker;

- allergy and immunology diseases;

- having bleeding tendency;

- pregnant or lactating women;

- having impaired hepatic or renal function;

- stroke or otherwise unable to exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Acupuncture
Eight body acupuncture points will be chosen as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli(ST-36), Fenlong(ST-40), Sanyinjiao(SP-6). The needles will be retained for 30 minutes. Participants of the treatment group will additionally receive unilateral auricular acupressure at four auricular points as Hunger, Shen men, Spleen and Stomach with Semen Vaccariae embedded within adhesive tape in each treatment session. Acupressure will be applied by the subjects with repeat pressing of the tape with fingertips for 3 minutes per point, 3 times per day. The embedded tape will be retained in-situ until the next visit and then the alternate side of ear will be treated.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hong Kong Baptist University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body weight during treatment and follow up measured by Omron KARADA Scan Body Composition & Scale The change in body weight will be assessed every two weeks during 8-week treatment and 8-week follow up
Secondary Change in Body Mass Index (BMI) during treatment and follow up The change in Body Mass Index (BMI) will be measured by Omron KARADA Scan Body Composition & Scale The change in BMI will be assessed every two weeks during 8-week treatment and 8-week follow up
Secondary Change in waist circumference during treatment and follow up The change in waist circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
Secondary Change in hip circumference The change in hip circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
Secondary Change in body fat percentage during treatment and follow up The change in body fat percentage will be measured by Omron KARADA Scan Body Composition & Scale The change in body fat percentage will be assessed every two weeks during 8-week treatment and 8-week follow up
Secondary Number of patients with adverse events after treatment Number of patients with adverse events after treatment will be recorded and compared among the two groups during 8-week treatment and 8-week follow up
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2